Credo Diagnostics Biomedical Email Format

Medical Equipment ManufacturingCentral Region, Singapore11-50 Employees

Credo Diagnostics Biomedical develops, manufactures, and commercializes rapid molecular diagnostic solutions designed for point-of-care use in human infectious diseases and animal health. The company aims to simplify testing workflows and reduce the cost of molecular assays, enabling faster clinical decision-making. It positions rapid POC molecular diagnostics as a potential driver of change in how healthcare for people and animals is managed.

Headquartered in Singapore, in the Central Region, the company operates as a medical equipment manufacturer with a small to mid-sized team. A notable milestone is the introduction of the VitaPCR platform in 2019, a rapid molecular testing system capable of detecting pathogens such as SARS-CoV-2, influenza, and RSV in roughly 20 minutes. Its offerings target clinical and veterinary settings where timely results support care decisions.

Sign up for free to view info

Company overview Employee directory